How to Get Vardenafil (Levitra/Staxyn) in Nevada

Nevada Permits Telehealth Prescribing for Vardenafil

Nevada law authorizes prescribing controlled and non-controlled medications through telehealth when the encounter includes a real-time audio-video consultation. Vardenafil is not a controlled substance at the federal or state level, which simplifies the prescribing pathway. Any provider licensed in Nevada (or holding a valid interstate compact license) can evaluate a patient and transmit a vardenafil prescription electronically to a Nevada pharmacy.

The Nevada State Board of Medical Examiners updated telehealth regulations in 2021 to align with expanded pandemic-era access rules, and several of those flexibilities became permanent through SB 5 (2021). A provider must document a clinical evaluation, confirm the absence of contraindications (nitrate use, alpha-blocker co-administration, severe hepatic impairment), and establish a patient-provider relationship before writing the prescription.

Telehealth visits for erectile dysfunction typically run 10 to 20 minutes. Most platforms ask patients to complete a medical intake form that screens for cardiovascular risk factors. The American Urological Association (AUA) guideline on ED recommends that prescribers assess cardiovascular fitness, medication interactions, and psychosocial contributors before initiating PDE5 inhibitor therapy. This standard applies equally to in-person and virtual encounters.

Nevada's telehealth framework does not require a prior in-person visit for non-controlled prescriptions. That means a first-time patient can receive a vardenafil prescription entirely through a video consultation.

Who Can Prescribe Vardenafil in Nevada

Three categories of clinicians hold prescriptive authority for vardenafil in Nevada: physicians (MD/DO), nurse practitioners (NP), and physician assistants (PA). Each follows a different regulatory pathway.

Physicians carry independent prescriptive authority. Board-certified urologists and primary care physicians write the majority of PDE5 inhibitor prescriptions nationally, with primary care accounting for roughly 70% of initial ED prescriptions according to data from the National Ambulatory Medical Care Survey. NPs in Nevada gained full practice authority in 2024 after completing a supervised transition period. They can independently evaluate, diagnose, and prescribe for erectile dysfunction without a collaborative agreement. PAs still practice under a collaborative agreement with a supervising physician but can prescribe vardenafil within that scope.

The practical difference for patients is small. Whether you see an MD, NP, or PA in a clinic or on a telehealth platform, the prescription carries the same legal weight and can be filled at any licensed Nevada pharmacy.

What Labs and Screening Are Needed Before a Prescription

No single lab test is mandatory before prescribing vardenafil, but clinical guidelines recommend targeted screening based on the patient's risk profile. The Endocrine Society's 2018 guideline on testosterone therapy recommends measuring morning total testosterone in men with ED symptoms, particularly when low libido accompanies erectile difficulties.

A standard pre-prescribing workup often includes:

• Fasting glucose or HbA1c to screen for diabetes, which affects 35-75% of men with ED depending on diabetes type and duration [1]
• Lipid panel to evaluate cardiovascular risk
• Total testosterone (morning draw) if hypogonadism is suspected
• Blood pressure measurement since uncontrolled hypertension is both an ED risk factor and a consideration for PDE5 inhibitor dosing
• Basic metabolic panel if renal function is a concern

In the key registration trial by Porst et al. (2003, N=580), vardenafil 10 mg and 20 mg significantly improved erectile function compared with placebo across a 12-week period, with 80% of intercourse attempts successful at the 20 mg dose compared to 30% on placebo [2]. That trial enrolled patients after screening for cardiovascular stability and medication interactions, a model that current clinical practice mirrors.

Telehealth platforms operating in Nevada typically request that patients upload recent lab results (within 12 months) or order labs through a partner laboratory. Quest Diagnostics and Labcorp both have multiple draw sites across Las Vegas, Reno, Henderson, and Sparks.

Filling the Prescription: Pharmacy Options in Nevada

Nevada has three main pharmacy channels for vardenafil: retail chain pharmacies, independent pharmacies, and 503A compounding pharmacies.

Retail and chain pharmacies. CVS, Walgreens, and Walmart locations across Nevada stock generic vardenafil. Since generic entry in 2018, the average cash price for 6 tablets of vardenafil 20 mg has dropped from over $350 (brand Levitra) to approximately $30-80 depending on the pharmacy and discount card used. GoodRx and similar aggregators show Nevada-specific pricing that fluctuates by zip code.

503A compounding pharmacies. Nevada's Board of Pharmacy licenses 503A compounding pharmacies that can prepare vardenafil in custom dosage forms (sublingual troches, flavored suspensions) or combination formulations when a prescriber writes a patient-specific prescription. These pharmacies can ship within Nevada. They cannot distribute across state lines without 503B outsourcing facility registration. For patients who need a non-standard dose or have difficulty swallowing tablets, compounding offers a legitimate alternative.

Mail-order pharmacy. Patients in rural Nevada counties (Elko, Humboldt, Pershing, White Pine) where brick-and-mortar pharmacy access is limited can use licensed mail-order pharmacies. The prescription must originate from a Nevada-licensed provider, and the dispensing pharmacy must hold a Nevada non-resident pharmacy license if based out of state. Delivery timelines range from 2 to 5 business days for standard shipping within the continental US.

The FDA-approved labeling for vardenafil specifies available strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg film-coated tablets, plus the Staxyn 10 mg orally disintegrating tablet. Staxyn is not interchangeable with Levitra on a milligram-per-milligram basis due to different bioavailability profiles, so pharmacists cannot automatically substitute one for the other.

Nevada Medicaid Does Not Cover Vardenafil for ED

Nevada Medicaid excludes erectile dysfunction drugs from its formulary. This exclusion follows the federal Medicaid statute (Social Security Act §1927(d)(2)), which gives states the option to exclude drugs used for ED, cosmetic purposes, or weight loss. Nevada exercises that option.

For patients enrolled in Nevada Medicaid, the out-of-pocket cost for generic vardenafil represents the full price. No prior authorization pathway exists within Medicaid for this indication because the drug class itself is excluded, not merely restricted.

Commercial insurance coverage varies. Some employer-sponsored plans cover generic vardenafil with a prior authorization. A 2019 analysis published in the Journal of Sexual Medicine found that among commercially insured men with ED, 43% of PDE5 inhibitor claims required prior authorization, and approval rates exceeded 85% when documentation included a confirmed ED diagnosis and a record of contraindications to non-pharmacologic therapy [3].

For patients paying cash, manufacturer discount cards and pharmacy discount programs reduce the cost significantly. Generic vardenafil 20 mg can be split (the tablets are scored) to yield two 10 mg doses, effectively halving the per-dose cost with prescriber approval.

Prior Authorization: What Documentation Nevada Insurers Require

When a commercial plan does require prior authorization for vardenafil, the documentation request typically includes:

• Confirmed diagnosis of erectile dysfunction (ICD-10 code N52.01-N52.9)
• Duration of symptoms
• Documentation of at least one failed non-pharmacologic intervention or clinical rationale for pharmacotherapy as first-line
• List of current medications to confirm no nitrate or alpha-blocker interaction
• Relevant lab results (testosterone, glucose)
• Prescriber attestation that the drug is medically necessary

Turnaround times for PA decisions in Nevada follow state insurance code: standard requests must be resolved within 5 business days, and urgent requests within 24 hours. The Nevada Division of Insurance enforces these timelines.

If a PA is denied, patients have the right to an internal appeal followed by an external review through the Nevada Bureau of Consumer Health Assistance. Dr. Arthur Burnett, a professor of urology at Johns Hopkins and lead author on the AUA ED guideline, has stated: "PDE5 inhibitors represent first-line pharmacotherapy for erectile dysfunction, and access barriers including prior authorization can delay treatment for a condition with significant quality-of-life impact" [4].

How Vardenafil Compares to Other PDE5 Inhibitors Available in Nevada

Nevada pharmacies stock all four FDA-approved PDE5 inhibitors: sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra/Staxyn), and avanafil (Stendra). The choice among them depends on onset speed, duration of action, side-effect profile, and cost.

Vardenafil reaches peak plasma concentration in 30 to 120 minutes, with a half-life of 4 to 5 hours [5]. Tadalafil has a much longer half-life (17.5 hours), making it suitable for daily dosing. Sildenafil and vardenafil have similar pharmacokinetic profiles, though vardenafil shows slightly higher selectivity for the PDE5 enzyme over PDE6, which may translate to fewer visual disturbances [6].

In a head-to-head crossover study (N=128) published in the Journal of Urology, patients reported comparable efficacy between sildenafil 100 mg and vardenafil 20 mg, but a subgroup with diabetes showed a numerically higher response rate with vardenafil (62% vs. 56%), though the difference did not reach statistical significance [7]. The AUA guideline does not recommend one PDE5 inhibitor over another as a class, instead advising clinicians to consider patient preference, cost, and comorbidities.

Generic pricing in Nevada as of 2026:

• Sildenafil 20 mg (off-label dose): $0.30-1.50 per tablet
• Tadalafil 5 mg (daily): $0.40-2.00 per tablet
• Vardenafil 20 mg: $5-13 per tablet
• Avanafil 100 mg: $30-55 per tablet (no generic)

Vardenafil sits in the mid-range. Patients for whom sildenafil causes headache or flushing sometimes respond better to vardenafil due to its slightly different binding affinity profile.

Transferring a Prescription to a Nevada Pharmacy

Patients relocating to Nevada or traveling within the state can transfer an existing vardenafil prescription from an out-of-state pharmacy. Nevada Board of Pharmacy regulations permit prescription transfers between licensed pharmacies, provided the prescription has remaining refills and was written by a provider whose license is verifiable.

The process works like this. The patient contacts the receiving Nevada pharmacy and provides the name and phone number of the originating pharmacy. The receiving pharmacist calls the originating pharmacy, verifies the prescription details, and processes the transfer. Electronic transfer through shared pharmacy networks (e.g., CVS-to-CVS) speeds the process to minutes. Cross-chain transfers may take up to 24 hours.

One exception: Staxyn (vardenafil ODT) is classified differently from standard vardenafil tablets in some pharmacy systems. If the original prescription specifies Staxyn by brand, the receiving pharmacy must stock or order that specific formulation. The Nevada pharmacist cannot dispense generic vardenafil tablets as a substitute for Staxyn without a new prescription.

The Nevada Board of Pharmacy recognizes prescriptions from all US-licensed prescribers. However, prescriptions written by providers in countries outside the US are not valid in Nevada and require a new evaluation by a Nevada-licensed clinician.

Safety Monitoring and Follow-Up

After starting vardenafil, the prescribing clinician should schedule a follow-up within 4 to 8 weeks to assess efficacy, side effects, and dose adjustment needs. The most common adverse effects in clinical trials were headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%) [2].

Patients taking vardenafil should not use nitrates in any form (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, or recreational amyl nitrite) due to the risk of severe hypotension. The ACC/AHA guideline on stable ischemic heart disease specifies a minimum 24-hour washout between vardenafil use and nitrate administration [8].

Dr. Ajay Nehra, former chair of the AUA ED guideline panel, noted in a 2018 commentary: "The safety profile of PDE5 inhibitors, including vardenafil, is well-established across two decades of post-marketing surveillance. The primary risk remains the drug-drug interaction with nitrates, which is entirely preventable through proper medication reconciliation" [4].

QT prolongation is a unique consideration for vardenafil compared with other PDE5 inhibitors. The FDA label notes a small mean increase in QTc interval (8-10 ms at 40 mg, which is twice the maximum recommended dose). Patients with congenital long QT syndrome or those taking Class IA or III antiarrhythmics (quinidine, procainamide, amiodarone, sotalol) should not use vardenafil [5].

Telehealth platforms serving Nevada patients typically build these screening questions into their intake forms. An automated flag triggers a pharmacist or provider review if the patient reports nitrate use, a history of arrhythmia, or concurrent alpha-blocker therapy.

Timelines: How Long Until You Receive Vardenafil in Nevada

The total time from initial consultation to medication in hand depends on the pathway:

• Telehealth visit + e-prescription to local pharmacy: Same day. The visit takes 10-20 minutes, the prescription transmits electronically within seconds, and most pharmacies fill vardenafil within 1-2 hours if it is in stock.
• Telehealth visit + mail-order pharmacy: 3-7 business days. Some platforms include the medication cost in the consultation fee and ship from their own licensed pharmacy.
• In-person visit + retail pharmacy: Same day if no lab work is needed. If the provider orders labs first, add 1-3 days for results.
• 503A compounding pharmacy: 3-10 business days depending on the formulation complexity and whether the pharmacy needs to source raw materials.

For patients in the Las Vegas or Reno metro areas, same-day access is realistic through most pathways. Rural patients should factor in shipping time or plan pharmacy visits during trips to larger cities.